Education
About Us
Working with TipRanks
Follow Us
Geratherm Medical AG (DE:GME)
XETRA:GME
Total Valuation
Geratherm Medical has a market cap or net worth of €38.01M. The enterprise value is €9.82M.
Market Cap€38.01M
Enterprise Value€9.82M
Share Statistics
Geratherm Medical has 5,444,998 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,444,998
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Geratherm Medical’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 4.50%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)4.50%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee114.11K
Profits Per Employee3.65K
Employee Count179
Asset Turnover0.72
Inventory Turnover1.30
Valuation Ratios
The current PE Ratio of Geratherm Medical is 12.6. Geratherm Medical’s PEG ratio is -0.70.
PE Ratio12.6
PS Ratio0.92
PB Ratio0.90
Price to Fair Value0.90
Price to FCF15.36
Price to Operating Cash Flow11.76
PEG Ratio-0.70
Income Statement
In the last 12 months, Geratherm Medical had revenue of 20.43M and earned 705.17K in profits. Earnings per share was 0.13.
Revenue20.43M
Gross Profit12.78M
Operating Income1.76M
Pretax Income982.00K
Net Income705.17K
EBITDA2.95M
Earnings Per Share (EPS)0.13
Cash Flow
In the last 12 months, operating cash flow was 2.79M and capital expenditures -117.00K, giving a free cash flow of 2.68M billion.
Operating Cash Flow2.79M
Free Cash Flow2.68M
Free Cash Flow per Share0.49
Dividends & Yields
Geratherm Medical pays an annual dividend of €0.1, resulting in a dividend yield of 2.44%
Dividend Per Share€0.1
Dividend Yield2.44%
Payout Ratio27.78%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.22
52-Week Price Change91.39%
50-Day Moving Average3.21
200-Day Moving Average3.24
Relative Strength Index (RSI)96.08
Average Volume (3m)2.43K
Important Dates
Geratherm Medical upcoming earnings date is Apr 29, 2026, TBA (Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateApr 29, 2026
Ex-Dividend DateJul 28, 2025
Financial Position
Geratherm Medical as a current ratio of 5.21, with Debt / Equity ratio of 12.57%
Current Ratio5.21
Quick Ratio3.55
Debt to Market Cap0.17
Net Debt to EBITDA-1.49
Interest Coverage Ratio16.27
Taxes
In the past 12 months, Geratherm Medical has paid 315.79K in taxes.
Income Tax315.79K
Effective Tax Rate0.32
Enterprise Valuation
Geratherm Medical EV to EBITDA ratio is 4.90, with an EV/FCF ratio of 11.77.
EV to Sales0.71
EV to EBITDA4.90
EV to Free Cash Flow11.77
EV to Operating Cash Flow7.73
Balance Sheet
Geratherm Medical has €9.61M in cash and marketable securities with €2.62M in debt, giving a net cash position of €6.99M billion.
Cash & Marketable Securities€9.61M
Total Debt€2.62M
Net Cash€6.99M
Net Cash Per Share€1.28
Tangible Book Value Per Share€3.55
Margins
Gross margin is 41.70%, with operating margin of 8.63%, and net profit margin of 3.45%.
Gross Margin41.70%
Operating Margin8.63%
Pretax Margin4.81%
Net Profit Margin3.45%
EBITDA Margin14.44%
EBIT Margin5.34%
Analyst Forecast
The average price target for Geratherm Medical is €3.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target€3.50
Price Target Upside-49.86% Downside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast-23.48%
EPS Growth Forecast―